- QuidelOrtho Corporation (QDEL, Financial) to announce Q1 2025 earnings on May 7, 2025.
- Conference call scheduled for 2:00 p.m. PT / 5:00 p.m. ET on the same day.
- Access to the call and presentation materials via the company's Investor Relations website.
QuidelOrtho Corporation (QDEL), a leader in in-vitro diagnostics, will report its financial results for the first quarter of 2025, which concluded on March 30, 2025. The announcement will be made after the market closes on Wednesday, May 7, 2025.
Following the financial release, QuidelOrtho will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the financial outcomes. Interested investors and analysts can access the webcast of the call through the “Events & Presentations” section available on the company's Investor Relations page on its website at https://ir.quidelortho.com. Presentation materials will also be accessible at the beginning of the call.
For those unable to join the webcast, the conference call can be accessed via phone by dialing 833-470-1428 in the U.S. or +1 929-526-1599 internationally, and entering the Conference ID number 170283. A replay of the call will be made available shortly after the event in the same “Events & Presentations” section of the website.
QuidelOrtho, renowned for its advancements in diagnostic technologies in various settings from home to hospital, offers expertise in immunoassay and molecular testing as well as clinical chemistry and transfusion medicine. The company remains committed to pioneering a more informed diagnostic frontier worldwide.
